We are happy to inform that we have successfully submitted our Dossier for Metoprolol Succinate 25/50/100/200 mg slow-release tablets to TGA (Therapeutic Good Administration – Australian Government).

Metoprolol is used for several purposes, including the treatment of essential hypertension in adults, cardiac arrhythmias, and angina pectoris.

This MA shall be available for transfer to our partners.

.

The Intas B2B Team

Published on March 3, 2022